<?xml version='1.0' encoding='utf-8'?>
<rss version="2.0">
  <channel>
    <title>Rx Shortage Radar - To Be Discontinued</title>
    <link>https://zzddddzz.github.io/rx-shortage-radar/</link>
    <description>Latest public FDA drug shortage records with status To Be Discontinued from openFDA.</description>
    <language>en-us</language>
    <lastBuildDate>Sat, 25 Apr 2026 10:06:10 GMT</lastBuildDate>
    <docs>https://open.fda.gov/apis/drug/drugshortages/</docs>
    <item>
      <title>To Be Discontinued: Palbociclib Capsule (0069-0187-21)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0069-0187-21</link>
      <guid isPermaLink="false">72a71ac53a471d26</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 GMT</pubDate>
      <description>Ibrance, Capsule, 75 mg (NDC 0069-0187-21)
Status: To Be Discontinued
Updated: 2026-04-22
Company: Pfizer Inc.
Discontinuation of the manufacturing of the capsule presentation. 75 mg Tablet 
NDC 0069-0284-03 will continue to be manufactured.</description>
    </item>
    <item>
      <title>To Be Discontinued: Palbociclib Capsule (0069-0188-21)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0069-0188-21</link>
      <guid isPermaLink="false">0ba9adc228d6bc8c</guid>
      <pubDate>Wed, 22 Apr 2026 00:00:00 GMT</pubDate>
      <description>Ibrance, Capsule, 100 mg (NDC 0069-0188-21)
Status: To Be Discontinued
Updated: 2026-04-22
Company: Pfizer Inc.
Discontinuation of the manufacturing of the capsule presentation. 100 mg Tablet NDC 0069-0486-03 will continue to be manufactured.</description>
    </item>
    <item>
      <title>To Be Discontinued: Dexmedetomidine Hydrochloride Injection (16729-239-93)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=16729-239-93</link>
      <guid isPermaLink="false">859c71b73fef0ede</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      <description>Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)
Status: To Be Discontinued
Updated: 2026-04-21
Company: Accord Healthcare Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Ketorolac Tromethamine Tablet (0378-1134-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0378-1134-01</link>
      <guid isPermaLink="false">1aed20ae4314bec7</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      <description>Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01)
Status: To Be Discontinued
Updated: 2026-04-20
Company: Mylan Pharmaceuticals Inc., a Viatris Company
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Rifampin Injection (0068-0597-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0068-0597-01</link>
      <guid isPermaLink="false">1129dcb137a62629</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      <description>Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)
Status: To Be Discontinued
Updated: 2026-04-20
Company: Sanofi-Aventis U.S. LLC
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Tiagabine Hydrochloride Tablet (0093-5030-56)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0093-5030-56</link>
      <guid isPermaLink="false">80e031ec041f3f59</guid>
      <pubDate>Wed, 15 Apr 2026 00:00:00 GMT</pubDate>
      <description>Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56)
Status: To Be Discontinued
Updated: 2026-04-15
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Tiagabine Hydrochloride Tablet (0093-5031-56)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0093-5031-56</link>
      <guid isPermaLink="false">43f84fdf0435adcd</guid>
      <pubDate>Wed, 15 Apr 2026 00:00:00 GMT</pubDate>
      <description>Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56)
Status: To Be Discontinued
Updated: 2026-04-15
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Tiagabine Hydrochloride Tablet (0093-8072-56)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0093-8072-56</link>
      <guid isPermaLink="false">6007a60011519e80</guid>
      <pubDate>Wed, 15 Apr 2026 00:00:00 GMT</pubDate>
      <description>Tiagabine Hydrochloride, Tablet, 12mg 30 count (NDC 0093-8072-56)
Status: To Be Discontinued
Updated: 2026-04-15
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Tiagabine Hydrochloride Tablet (0093-8076-56)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0093-8076-56</link>
      <guid isPermaLink="false">9e2af2a2f9388455</guid>
      <pubDate>Wed, 15 Apr 2026 00:00:00 GMT</pubDate>
      <description>Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56)
Status: To Be Discontinued
Updated: 2026-04-15
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nitroglycerin Ointment (58914-301-80)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=58914-301-80</link>
      <guid isPermaLink="false">ce396294290d3516</guid>
      <pubDate>Tue, 14 Apr 2026 00:00:00 GMT</pubDate>
      <description>Rectiv, Ointment, 0.4% (NDC 58914-301-80)
Status: To Be Discontinued
Updated: 2026-04-14
Company: AbbVie Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nitrofurantoin Oral Suspension (69238-2512-9)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=69238-2512-9</link>
      <guid isPermaLink="false">22e60d67a4823971</guid>
      <pubDate>Fri, 10 Apr 2026 00:00:00 GMT</pubDate>
      <description>Nitrofurantoin, Oral Suspension, 25 mg/5 mL (NDC 69238-2512-9)
Status: To Be Discontinued
Updated: 2026-04-10
Company: Amneal Pharmaceuticals
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Azithromycin Tablet (0069-3070-30)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0069-3070-30</link>
      <guid isPermaLink="false">829563bb645d4fb5</guid>
      <pubDate>Thu, 09 Apr 2026 00:00:00 GMT</pubDate>
      <description>Zithromax, Tablet, 500 mg (NDC 0069-3070-30)
Status: To Be Discontinued
Updated: 2026-04-09
Company: Pfizer Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Azithromycin Tablet (0069-4061-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0069-4061-01</link>
      <guid isPermaLink="false">9f734a327200e566</guid>
      <pubDate>Thu, 09 Apr 2026 00:00:00 GMT</pubDate>
      <description>Zithromax, Tablet, 250 mg (NDC 0069-4061-01)
Status: To Be Discontinued
Updated: 2026-04-09
Company: Pfizer Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Aprepitant Oral Powder for Suspension (0006-3066-03)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0006-3066-03</link>
      <guid isPermaLink="false">156f4220ba8b4bd6</guid>
      <pubDate>Wed, 08 Apr 2026 00:00:00 GMT</pubDate>
      <description>Emend, Oral Powder for Suspension, 125 mg (NDC 0006-3066-03)
Status: To Be Discontinued
Updated: 2026-04-08
Company: Merck Sharp &amp; Dohme LLC
To be discontinued in approximately November 2026.</description>
    </item>
    <item>
      <title>To Be Discontinued: Fosaprepitant Dimeglumine Injection (63323-972-10)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=63323-972-10</link>
      <guid isPermaLink="false">c658994be6982271</guid>
      <pubDate>Wed, 08 Apr 2026 00:00:00 GMT</pubDate>
      <description>Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)
Status: To Be Discontinued
Updated: 2026-04-08
Company: Fresenius Kabi USA, LLC
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Idelalisib Tablet (61958-1701-1)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=61958-1701-1</link>
      <guid isPermaLink="false">206505af4e64709f</guid>
      <pubDate>Tue, 07 Apr 2026 00:00:00 GMT</pubDate>
      <description>Zydelig, Tablet, 100 mg (NDC 61958-1701-1)
Status: To Be Discontinued
Updated: 2026-04-07
Company: Gilead Sciences, Inc.
Discontinuation in the manufacturing of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Idelalisib Tablet (61958-1702-1)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=61958-1702-1</link>
      <guid isPermaLink="false">4c7ac649a1a390aa</guid>
      <pubDate>Tue, 07 Apr 2026 00:00:00 GMT</pubDate>
      <description>Zydelig, Tablet, 150 mg (NDC 61958-1702-1)
Status: To Be Discontinued
Updated: 2026-04-07
Company: Gilead Sciences, Inc.
Discontinuation in the manufacturing of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Ursodiol Capsule (64380-844-06)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=64380-844-06</link>
      <guid isPermaLink="false">d11e8772f2a575da</guid>
      <pubDate>Mon, 06 Apr 2026 00:00:00 GMT</pubDate>
      <description>Ursodiol, Capsule, 300 mg (NDC 64380-844-06)
Status: To Be Discontinued
Updated: 2026-04-06
Company: Strides Pharma Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Icosapent Ethyl Capsule (60429-005-12)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=60429-005-12</link>
      <guid isPermaLink="false">f2e28e7c1d699543</guid>
      <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
      <description>Icosapent Ethyl, Capsule, 1 g (NDC 60429-005-12)
Status: To Be Discontinued
Updated: 2026-04-01
Company: Apotex Corp.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Icosapent Ethyl Capsule (61474-9711-1)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=61474-9711-1</link>
      <guid isPermaLink="false">04170e3e599fa505</guid>
      <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
      <description>Icosapent Ethyl, Capsule, 1 g (NDC 61474-9711-1)
Status: To Be Discontinued
Updated: 2026-04-01
Company: Apotex Corp.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Dapsone Gel (69238-1627-6)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=69238-1627-6</link>
      <guid isPermaLink="false">383589bc5d7f7cc2</guid>
      <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
      <description>Dapsone, Gel, 7.5% (NDC 69238-1627-6)
Status: To Be Discontinued
Updated: 2026-03-27
Company: Amneal Pharmaceuticals
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Progesterone Vaginal Gel (0023-6150-04)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0023-6150-04</link>
      <guid isPermaLink="false">d34fb3ba09e005e5</guid>
      <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
      <description>Crinone, Vaginal Gel, 4% (NDC 0023-6150-04)
Status: To Be Discontinued
Updated: 2026-03-27
Company: AbbVie Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Tazemetostat Hydrobromide Tablet (72607-100-00)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=72607-100-00</link>
      <guid isPermaLink="false">f17afbcd5f1636f2</guid>
      <pubDate>Fri, 27 Mar 2026 00:00:00 GMT</pubDate>
      <description>Tazverik, Tablet, 200 mg (NDC 72607-100-00)
Status: To Be Discontinued
Updated: 2026-03-27
Company: Epizyme, Inc. (An Ipsen Company)
Discontinuation of the manufacture of the drug product</description>
    </item>
    <item>
      <title>To Be Discontinued: Clindamycin Palmitate Hydrochloride Injection (53746-468-19)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=53746-468-19</link>
      <guid isPermaLink="false">bd9c64c627da4898</guid>
      <pubDate>Thu, 26 Mar 2026 00:00:00 GMT</pubDate>
      <description>Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)
Status: To Be Discontinued
Updated: 2026-03-26
Company: Amneal Pharmaceuticals
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Lincomycin Hydrochloride Injection (39822-0350-2)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=39822-0350-2</link>
      <guid isPermaLink="false">ef66e0c933076d7e</guid>
      <pubDate>Thu, 26 Mar 2026 00:00:00 GMT</pubDate>
      <description>Lincomycin Hydrochloride, Injection, 600 mg/2 mL vial x 10 count (NDC 39822-0350-2)
Status: To Be Discontinued
Updated: 2026-03-26
Company: XGen Pharmaceuticals DJB, Inc.
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Lincomycin Hydrochloride Injection (39822-0355-6)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=39822-0355-6</link>
      <guid isPermaLink="false">f2d0a31081ad3842</guid>
      <pubDate>Thu, 26 Mar 2026 00:00:00 GMT</pubDate>
      <description>Lincomycin Hydrochloride, Injection, 3 grams/10 mL vial x 10 count (NDC 39822-0355-6)
Status: To Be Discontinued
Updated: 2026-03-26
Company: XGen Pharmaceuticals DJB, Inc.
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-353-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-353-01</link>
      <guid isPermaLink="false">c87db89faf62984a</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-01)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-353-05)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-353-05</link>
      <guid isPermaLink="false">2cf77cbc28c11647</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-05)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-353-30)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-353-30</link>
      <guid isPermaLink="false">1496d59736c77dd8</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-30)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-353-90)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-353-90</link>
      <guid isPermaLink="false">340a5de276df1a31</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-90)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-354-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-354-01</link>
      <guid isPermaLink="false">855b411f06f746af</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-01)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-354-05)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-354-05</link>
      <guid isPermaLink="false">2a94c9e8f72fa449</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-05)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-354-30)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-354-30</link>
      <guid isPermaLink="false">b44395d2a94a42c2</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-30)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-354-90)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-354-90</link>
      <guid isPermaLink="false">aa2df0668fe7d56b</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-90)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-355-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-355-01</link>
      <guid isPermaLink="false">e23f69ab0775d01d</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-01)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-355-05)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-355-05</link>
      <guid isPermaLink="false">605c004164675023</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-05)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-355-30)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-355-30</link>
      <guid isPermaLink="false">5b22bd0ace1495f1</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-30)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-355-90)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-355-90</link>
      <guid isPermaLink="false">18e5bb613f8aad35</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-90)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-356-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-356-01</link>
      <guid isPermaLink="false">0806cd8c898b31c7</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-01)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-356-05)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-356-05</link>
      <guid isPermaLink="false">1a953561168d13ab</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-05)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-356-30)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-356-30</link>
      <guid isPermaLink="false">ec8dcbdb526de488</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-30)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Nebivolol Hydrochloride Tablet (13668-356-90)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=13668-356-90</link>
      <guid isPermaLink="false">753efecd59fda542</guid>
      <pubDate>Wed, 25 Mar 2026 00:00:00 GMT</pubDate>
      <description>Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-90)
Status: To Be Discontinued
Updated: 2026-03-25
Company: Torrent Pharmaceuticals Limited
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Ivabradine Hydrochloride Tablet (55513-800-60)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=55513-800-60</link>
      <guid isPermaLink="false">285f1d8cf9e9ad50</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <description>Corlanor, Tablet, eq. 5 mg base (NDC 55513-800-60)
Status: To Be Discontinued
Updated: 2026-03-24
Company: Amgen Inc.
Discontinuation of the manufacture of the drug product</description>
    </item>
    <item>
      <title>To Be Discontinued: Ivabradine Hydrochloride Tablet (55513-810-60)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=55513-810-60</link>
      <guid isPermaLink="false">598207304ccb1215</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <description>Corlanor, Tablet, eq. 7.5 mg base (NDC 55513-810-60)
Status: To Be Discontinued
Updated: 2026-03-24
Company: Amgen Inc.
Discontinuation of the manufacture of the drug product</description>
    </item>
    <item>
      <title>To Be Discontinued: Ivabradine Solution (55513-813-28)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=55513-813-28</link>
      <guid isPermaLink="false">6b9a71bb20e5c64f</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <description>Corlanor, Solution, 5 mg/5 mL (NDC 55513-813-28)
Status: To Be Discontinued
Updated: 2026-03-24
Company: Amgen Inc.
Discontinuation of the manufacture of the drug product</description>
    </item>
    <item>
      <title>To Be Discontinued: Pilocarpine Hydrochloride Ophthalmic Solution (0074-7098-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0074-7098-01</link>
      <guid isPermaLink="false">2a961d0065df1031</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <description>Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-01)
Status: To Be Discontinued
Updated: 2026-03-24
Company: AbbVie Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Pilocarpine Hydrochloride Ophthalmic Solution (0074-7098-03)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0074-7098-03</link>
      <guid isPermaLink="false">efea17838dc7b22f</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <description>Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-03)
Status: To Be Discontinued
Updated: 2026-03-24
Company: AbbVie Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Pilocarpine Hydrochloride Ophthalmic Solution (0074-7098-04)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0074-7098-04</link>
      <guid isPermaLink="false">cb074436e650fcb2</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <description>Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-04)
Status: To Be Discontinued
Updated: 2026-03-24
Company: AbbVie Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Pilocarpine Hydrochloride Ophthalmic Solution (0074-7098-05)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0074-7098-05</link>
      <guid isPermaLink="false">c7f281775e071603</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <description>Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-05)
Status: To Be Discontinued
Updated: 2026-03-24
Company: AbbVie Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Pilocarpine Hydrochloride Ophthalmic Solution (0074-7098-06)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0074-7098-06</link>
      <guid isPermaLink="false">3a64c9cc3057714f</guid>
      <pubDate>Tue, 24 Mar 2026 00:00:00 GMT</pubDate>
      <description>Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-06)
Status: To Be Discontinued
Updated: 2026-03-24
Company: AbbVie Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Pentamidine Isethionate Injection (39822-3050-2)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=39822-3050-2</link>
      <guid isPermaLink="false">4953922dd25c0655</guid>
      <pubDate>Mon, 23 Mar 2026 00:00:00 GMT</pubDate>
      <description>Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2)
Status: To Be Discontinued
Updated: 2026-03-23
Company: XGen Pharmaceuticals DJB, Inc.
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Ramelteon Tablet (64764-805-10)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=64764-805-10</link>
      <guid isPermaLink="false">80a2f0f98bd8e6bd</guid>
      <pubDate>Thu, 19 Mar 2026 00:00:00 GMT</pubDate>
      <description>Rozerem, Tablet, 8 mg (NDC 64764-805-10)
Status: To Be Discontinued
Updated: 2026-03-19
Company: Takeda Pharmaceuticals USA Inc.
Product is expected to be available through February 2027.</description>
    </item>
    <item>
      <title>To Be Discontinued: Ramelteon Tablet (64764-805-30)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=64764-805-30</link>
      <guid isPermaLink="false">f87d12af97b94371</guid>
      <pubDate>Thu, 19 Mar 2026 00:00:00 GMT</pubDate>
      <description>Rozerem, Tablet, 8 mg (NDC 64764-805-30)
Status: To Be Discontinued
Updated: 2026-03-19
Company: Takeda Pharmaceuticals USA Inc.
Product is expected to be available through June 2027.</description>
    </item>
    <item>
      <title>To Be Discontinued: Plerixafor Injection (65219-284-12)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=65219-284-12</link>
      <guid isPermaLink="false">1cb1ff55e10e3e61</guid>
      <pubDate>Fri, 13 Mar 2026 00:00:00 GMT</pubDate>
      <description>Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12)
Status: To Be Discontinued
Updated: 2026-03-13
Company: Fresenius Kabi USA, LLC
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Peritoneal Dialysis Solution (46163-206-92)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=46163-206-92</link>
      <guid isPermaLink="false">6f228bdd25bfbc43</guid>
      <pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate>
      <description>DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2L, 5/cs (NDC 46163-206-92)
Status: To Be Discontinued
Updated: 2026-03-10
Company: Fresenius Medical Care North America
The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.</description>
    </item>
    <item>
      <title>To Be Discontinued: Peritoneal Dialysis Solution (46163-212-92)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=46163-212-92</link>
      <guid isPermaLink="false">5d2afceec5a5db95</guid>
      <pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate>
      <description>DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2L, 5/cs (NDC 46163-212-92)
Status: To Be Discontinued
Updated: 2026-03-10
Company: Fresenius Medical Care North America
The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.</description>
    </item>
    <item>
      <title>To Be Discontinued: Peritoneal Dialysis Solution (46163-212-94)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=46163-212-94</link>
      <guid isPermaLink="false">b8499d50515bb2c5</guid>
      <pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate>
      <description>DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 46163-212-94)
Status: To Be Discontinued
Updated: 2026-03-10
Company: Fresenius Medical Care North America
The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.</description>
    </item>
    <item>
      <title>To Be Discontinued: Peritoneal Dialysis Solution (49230-206-94)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=49230-206-94</link>
      <guid isPermaLink="false">15b6960d134f3da0</guid>
      <pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate>
      <description>DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-206-94)
Status: To Be Discontinued
Updated: 2026-03-10
Company: Fresenius Medical Care North America
The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.</description>
    </item>
    <item>
      <title>To Be Discontinued: Peritoneal Dialysis Solution (49230-209-92)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=49230-209-92</link>
      <guid isPermaLink="false">3aaef08491effdf0</guid>
      <pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate>
      <description>DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2L, 5/cs (NDC 49230-209-92)
Status: To Be Discontinued
Updated: 2026-03-10
Company: Fresenius Medical Care North America
The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.</description>
    </item>
    <item>
      <title>To Be Discontinued: Peritoneal Dialysis Solution (49230-209-94)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=49230-209-94</link>
      <guid isPermaLink="false">0b45f07dbeeecfd9</guid>
      <pubDate>Tue, 10 Mar 2026 00:00:00 GMT</pubDate>
      <description>DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-209-94)
Status: To Be Discontinued
Updated: 2026-03-10
Company: Fresenius Medical Care North America
The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.</description>
    </item>
    <item>
      <title>To Be Discontinued: Everolimus Tablet (0093-7766-24)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0093-7766-24</link>
      <guid isPermaLink="false">cac8127c71aa69b8</guid>
      <pubDate>Mon, 02 Mar 2026 00:00:00 GMT</pubDate>
      <description>Everolimus, Tablet, 2.5 mg (NDC 0093-7766-24)
Status: To Be Discontinued
Updated: 2026-03-02
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Everolimus Tablet (0093-7767-24)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0093-7767-24</link>
      <guid isPermaLink="false">0d85d78e818cf579</guid>
      <pubDate>Mon, 02 Mar 2026 00:00:00 GMT</pubDate>
      <description>Everolimus, Tablet, 5 mg (NDC 0093-7767-24)
Status: To Be Discontinued
Updated: 2026-03-02
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Everolimus Tablet (0093-7768-24)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0093-7768-24</link>
      <guid isPermaLink="false">36d194f3d95b2e3a</guid>
      <pubDate>Mon, 02 Mar 2026 00:00:00 GMT</pubDate>
      <description>Everolimus, Tablet, 7.5 mg (NDC 0093-7768-24)
Status: To Be Discontinued
Updated: 2026-03-02
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Everolimus Tablet (0093-7769-24)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0093-7769-24</link>
      <guid isPermaLink="false">aa645931a74d5689</guid>
      <pubDate>Mon, 02 Mar 2026 00:00:00 GMT</pubDate>
      <description>Everolimus, Tablet, 10 mg (NDC 0093-7769-24)
Status: To Be Discontinued
Updated: 2026-03-02
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Clindamycin Palmitate Hydrochloride Injection (53746-468-19)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=53746-468-19</link>
      <guid isPermaLink="false">8e94b7b7c41401e2</guid>
      <pubDate>Fri, 27 Feb 2026 00:00:00 GMT</pubDate>
      <description>Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)
Status: To Be Discontinued
Updated: 2026-02-27
Company: Amneal Pharmaceuticals
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Itraconazole Capsule (10147-1700-3)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=10147-1700-3</link>
      <guid isPermaLink="false">55cf598aa157b16a</guid>
      <pubDate>Fri, 27 Feb 2026 00:00:00 GMT</pubDate>
      <description>Sporanox, Capsule, 100 mg (NDC 10147-1700-3)
Status: To Be Discontinued
Updated: 2026-02-27
Company: Janssen Pharmaceuticals
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Itraconazole Capsule (50458-290-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=50458-290-01</link>
      <guid isPermaLink="false">ef886e72f07952e0</guid>
      <pubDate>Fri, 27 Feb 2026 00:00:00 GMT</pubDate>
      <description>Sporanox, Capsule, 100 mg (NDC 50458-290-01)
Status: To Be Discontinued
Updated: 2026-02-27
Company: Janssen Pharmaceuticals
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Itraconazole Capsule (50458-290-04)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=50458-290-04</link>
      <guid isPermaLink="false">030a6bf39f6407c0</guid>
      <pubDate>Fri, 27 Feb 2026 00:00:00 GMT</pubDate>
      <description>Sporanox, Capsule, 100 mg (NDC 50458-290-04)
Status: To Be Discontinued
Updated: 2026-02-27
Company: Janssen Pharmaceuticals
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Clindamycin Hydrochloride Capsule (0009-0225-02)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0009-0225-02</link>
      <guid isPermaLink="false">428f384effde023a</guid>
      <pubDate>Wed, 25 Feb 2026 00:00:00 GMT</pubDate>
      <description>Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02)
Status: To Be Discontinued
Updated: 2026-02-25
Company: Pfizer Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Clindamycin Hydrochloride Capsule (0009-0331-02)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0009-0331-02</link>
      <guid isPermaLink="false">5ab6c34df31857a7</guid>
      <pubDate>Wed, 25 Feb 2026 00:00:00 GMT</pubDate>
      <description>Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02)
Status: To Be Discontinued
Updated: 2026-02-25
Company: Pfizer Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Clindamycin Hydrochloride Capsule (0009-0395-14)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0009-0395-14</link>
      <guid isPermaLink="false">9b0355ffdb126d85</guid>
      <pubDate>Wed, 25 Feb 2026 00:00:00 GMT</pubDate>
      <description>Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14)
Status: To Be Discontinued
Updated: 2026-02-25
Company: Pfizer Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Lincomycin Hydrochloride Injection (0009-0104-04)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0009-0104-04</link>
      <guid isPermaLink="false">688a997ff877d5bd</guid>
      <pubDate>Wed, 25 Feb 2026 00:00:00 GMT</pubDate>
      <description>Lincocin, Injection, 2 mL multiple dose vial (NDC 0009-0104-04)
Status: To Be Discontinued
Updated: 2026-02-25
Company: Pfizer Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Oxaliplatin Injection (63323-750-10)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=63323-750-10</link>
      <guid isPermaLink="false">78821727bf836ce5</guid>
      <pubDate>Wed, 25 Feb 2026 00:00:00 GMT</pubDate>
      <description>Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10)
Status: To Be Discontinued
Updated: 2026-02-25
Company: Fresenius Kabi USA, LLC
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Oxaliplatin Injection (63323-750-20)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=63323-750-20</link>
      <guid isPermaLink="false">c32ed195e06b85a4</guid>
      <pubDate>Wed, 25 Feb 2026 00:00:00 GMT</pubDate>
      <description>Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20)
Status: To Be Discontinued
Updated: 2026-02-25
Company: Fresenius Kabi USA, LLC
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Arsenic Trioxide Injection (50742-438-10)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=50742-438-10</link>
      <guid isPermaLink="false">e57b25d5c67730aa</guid>
      <pubDate>Tue, 24 Feb 2026 00:00:00 GMT</pubDate>
      <description>Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 50742-438-10)
Status: To Be Discontinued
Updated: 2026-02-24
Company: Ingenus Pharmaceuticals LLC
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Frovatriptan Succinate Tablet (63481-025-09)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=63481-025-09</link>
      <guid isPermaLink="false">a83c25bcb25259bd</guid>
      <pubDate>Tue, 24 Feb 2026 00:00:00 GMT</pubDate>
      <description>Frova, Tablet, 2.5 mg (NDC 63481-025-09)
Status: To Be Discontinued
Updated: 2026-02-24
Company: Endo Pharmaceuticals, Inc.
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Irinotecan Hydrochloride Injection (50742-401-02)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=50742-401-02</link>
      <guid isPermaLink="false">e4a279bff2f4786a</guid>
      <pubDate>Tue, 24 Feb 2026 00:00:00 GMT</pubDate>
      <description>Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02)
Status: To Be Discontinued
Updated: 2026-02-24
Company: Ingenus Pharmaceuticals LLC
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Irinotecan Hydrochloride Injection (50742-402-05)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=50742-402-05</link>
      <guid isPermaLink="false">0395d60bd2565905</guid>
      <pubDate>Tue, 24 Feb 2026 00:00:00 GMT</pubDate>
      <description>Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 50742-402-05)
Status: To Be Discontinued
Updated: 2026-02-24
Company: Ingenus Pharmaceuticals LLC
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Carboplatin Injection (50742-447-45)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=50742-447-45</link>
      <guid isPermaLink="false">8eb2de3834fee02a</guid>
      <pubDate>Fri, 20 Feb 2026 00:00:00 GMT</pubDate>
      <description>Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45)
Status: To Be Discontinued
Updated: 2026-02-20
Company: Ingenus Pharmaceuticals LLC
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Carboplatin Injection (50742-448-60)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=50742-448-60</link>
      <guid isPermaLink="false">f7ed184b6c2af816</guid>
      <pubDate>Fri, 20 Feb 2026 00:00:00 GMT</pubDate>
      <description>Carboplatin, Injection, 600 mg/60 mL (NDC 50742-448-60)
Status: To Be Discontinued
Updated: 2026-02-20
Company: Ingenus Pharmaceuticals LLC
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Decitabine Injection (50742-430-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=50742-430-01</link>
      <guid isPermaLink="false">2627ad0dda7e15b8</guid>
      <pubDate>Fri, 20 Feb 2026 00:00:00 GMT</pubDate>
      <description>Decitabine, Injection, 50 mg (NDC 50742-430-01)
Status: To Be Discontinued
Updated: 2026-02-20
Company: Ingenus Pharmaceuticals LLC
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Decitabine Injection (68001-573-41)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=68001-573-41</link>
      <guid isPermaLink="false">9cf58bcaa4c28e01</guid>
      <pubDate>Fri, 20 Feb 2026 00:00:00 GMT</pubDate>
      <description>Decitabine, Injection, 50 mg (NDC 68001-573-41)
Status: To Be Discontinued
Updated: 2026-02-20
Company: Ingenus Pharmaceuticals LLC
Labeler: BluePoint Laboratories; Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Docetaxel Injection (50742-431-08)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=50742-431-08</link>
      <guid isPermaLink="false">8d3275cf09a1f47e</guid>
      <pubDate>Fri, 20 Feb 2026 00:00:00 GMT</pubDate>
      <description>Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08)
Status: To Be Discontinued
Updated: 2026-02-20
Company: Ingenus Pharmaceuticals LLC
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Docetaxel Injection (50742-463-16)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=50742-463-16</link>
      <guid isPermaLink="false">62a61c910f552786</guid>
      <pubDate>Fri, 20 Feb 2026 00:00:00 GMT</pubDate>
      <description>Docetaxel, Injection, 10 mg/1 mL (NDC 50742-463-16)
Status: To Be Discontinued
Updated: 2026-02-20
Company: Ingenus Pharmaceuticals LLC
A business decision was made to discontinue manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Allopurinol Tablet (0591-5543-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0591-5543-01</link>
      <guid isPermaLink="false">4861429e4da81f2e</guid>
      <pubDate>Thu, 19 Feb 2026 00:00:00 GMT</pubDate>
      <description>Allopurinol, Tablet, 100 mg (NDC 0591-5543-01)
Status: To Be Discontinued
Updated: 2026-02-19
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Allopurinol Tablet (0591-5543-10)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0591-5543-10</link>
      <guid isPermaLink="false">0139d291729191cb</guid>
      <pubDate>Thu, 19 Feb 2026 00:00:00 GMT</pubDate>
      <description>Allopurinol, Tablet, 100 mg (NDC 0591-5543-10)
Status: To Be Discontinued
Updated: 2026-02-19
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Allopurinol Tablet (0591-5544-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0591-5544-01</link>
      <guid isPermaLink="false">9831e82e0500914b</guid>
      <pubDate>Thu, 19 Feb 2026 00:00:00 GMT</pubDate>
      <description>Allopurinol, Tablet, 300 mg (NDC 0591-5544-01)
Status: To Be Discontinued
Updated: 2026-02-19
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Allopurinol Tablet (0591-5544-05)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0591-5544-05</link>
      <guid isPermaLink="false">4e1dcd60fd48f9f8</guid>
      <pubDate>Thu, 19 Feb 2026 00:00:00 GMT</pubDate>
      <description>Allopurinol, Tablet, 300 mg (NDC 0591-5544-05)
Status: To Be Discontinued
Updated: 2026-02-19
Company: Teva Pharmaceuticals USA, Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Cefepime Hydrochloride Injection (63323-326-20)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=63323-326-20</link>
      <guid isPermaLink="false">a507ef1087bcdc9d</guid>
      <pubDate>Tue, 10 Feb 2026 00:00:00 GMT</pubDate>
      <description>Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20)
Status: To Be Discontinued
Updated: 2026-02-10
Company: Fresenius Kabi USA, LLC
Discontinuation of the manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Cefepime Hydrochloride Injection (63323-340-20)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=63323-340-20</link>
      <guid isPermaLink="false">8f2d5fb8aca4cb37</guid>
      <pubDate>Tue, 10 Feb 2026 00:00:00 GMT</pubDate>
      <description>Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)
Status: To Be Discontinued
Updated: 2026-02-10
Company: Fresenius Kabi USA, LLC
Discontinuation of the manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Chlorothiazide Oral Suspension (65649-311-12)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=65649-311-12</link>
      <guid isPermaLink="false">63b6ee486ae71a19</guid>
      <pubDate>Tue, 10 Feb 2026 00:00:00 GMT</pubDate>
      <description>Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12)
Status: To Be Discontinued
Updated: 2026-02-10
Company: Salix Pharmaceuticals, a division of Bausch Health US, LLC</description>
    </item>
    <item>
      <title>To Be Discontinued: Gemfibrozil Tablet (0071-0737-20)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0071-0737-20</link>
      <guid isPermaLink="false">872918479c4a9103</guid>
      <pubDate>Tue, 10 Feb 2026 00:00:00 GMT</pubDate>
      <description>Lopid, Tablet, 600 mg (NDC 0071-0737-20)
Status: To Be Discontinued
Updated: 2026-02-10
Company: Pfizer Inc.
Discontinuation of the manufacture of the drug.</description>
    </item>
    <item>
      <title>To Be Discontinued: Pindolol Tablet (57664-655-88)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=57664-655-88</link>
      <guid isPermaLink="false">382b9df7d854f7c6</guid>
      <pubDate>Fri, 30 Jan 2026 00:00:00 GMT</pubDate>
      <description>Pindolol, Tablet, 5 mg (NDC 57664-655-88)
Status: To Be Discontinued
Updated: 2026-01-30
Company: Sun Pharmaceutical Industries, Inc.
Discontinuation of the manufacture of the drug; Expiry date of last distributed batch January 2027</description>
    </item>
    <item>
      <title>To Be Discontinued: Pindolol Tablet (57664-656-88)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=57664-656-88</link>
      <guid isPermaLink="false">2ad6663c6b508e3a</guid>
      <pubDate>Fri, 30 Jan 2026 00:00:00 GMT</pubDate>
      <description>Pindolol, Tablet, 10 mg (NDC 57664-656-88)
Status: To Be Discontinued
Updated: 2026-01-30
Company: Sun Pharmaceutical Industries, Inc.
Discontinuation of the manufacture of the drug; Expiry date of last distributed batch October 2026</description>
    </item>
    <item>
      <title>To Be Discontinued: Podofilox Topical Gel (0023-6118-03)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0023-6118-03</link>
      <guid isPermaLink="false">90fe3790826a152f</guid>
      <pubDate>Wed, 28 Jan 2026 00:00:00 GMT</pubDate>
      <description>Condylox , Topical Gel, 0.5% (NDC 0023-6118-03)
Status: To Be Discontinued
Updated: 2026-01-28
Company: AbbVie Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Benztropine Mesylate Injection (63323-970-02)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=63323-970-02</link>
      <guid isPermaLink="false">654f89e13cd2a564</guid>
      <pubDate>Tue, 27 Jan 2026 00:00:00 GMT</pubDate>
      <description>Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02)
Status: To Be Discontinued
Updated: 2026-01-27
Company: Fresenius Kabi USA, LLC
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Fluvastatin Sodium Tablet, Extended Release (0781-8017-01)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0781-8017-01</link>
      <guid isPermaLink="false">76c0a52052ce661c</guid>
      <pubDate>Tue, 27 Jan 2026 00:00:00 GMT</pubDate>
      <description>Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-01)
Status: To Be Discontinued
Updated: 2026-01-27
Company: Sandoz Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Fluvastatin Sodium Tablet, Extended Release (0781-8017-31)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0781-8017-31</link>
      <guid isPermaLink="false">86f3dcc42650eab1</guid>
      <pubDate>Tue, 27 Jan 2026 00:00:00 GMT</pubDate>
      <description>Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-31)
Status: To Be Discontinued
Updated: 2026-01-27
Company: Sandoz Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Fluvastatin Sodium Tablet, Extended Release (66758-211-31)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=66758-211-31</link>
      <guid isPermaLink="false">12c3fd615fb91d52</guid>
      <pubDate>Tue, 27 Jan 2026 00:00:00 GMT</pubDate>
      <description>Lescol XL, Tablet, Extended Release, 80 mg (NDC 66758-211-31)
Status: To Be Discontinued
Updated: 2026-01-27
Company: Sandoz Inc.
Discontinuation of the manufacture of the drug</description>
    </item>
    <item>
      <title>To Be Discontinued: Azithromycin Injection (0069-3150-83)</title>
      <link>https://zzddddzz.github.io/rx-shortage-radar/?q=0069-3150-83</link>
      <guid isPermaLink="false">d9dfbf19ec781606</guid>
      <pubDate>Tue, 20 Jan 2026 00:00:00 GMT</pubDate>
      <description>Zithromax IV, Injection, 500 mg/5 mL (NDC 0069-3150-83)
Status: To Be Discontinued
Updated: 2026-01-20
Company: Pfizer Inc.
Discontinuation of the manufacture of the drug.</description>
    </item>
  </channel>
</rss>
